Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19

Jun Wang1,2,3, Qian Li3,4, Yongmei Yin5

  • 1Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi, Jiangnan University, Wuxi, China.

Frontiers in Immunology
|October 5, 2020
PubMed

Insights

Severe COVID-19 pneumonia involves excessive neutrophils and neutrophil extracellular traps (NETs). These findings help explain the lung injury observed in patients with coronavirus disease.

Area of Science:

  • Immunology
  • Pulmonology
  • Virology

Background:

  • Severe coronavirus disease (COVID-19) is associated with elevated neutrophil counts.
  • Pathological findings show neutrophil infiltration in COVID-19 autopsies.
  • Understanding neutrophil-driven pathogenesis in severe COVID-19 pneumonia is critical.

Purpose of the Study:

  • To investigate the role of neutrophils in the pathogenesis of severe pneumonia in COVID-19 patients.
  • To correlate neutrophil counts with lung injury progression in COVID-19.
  • To explore the molecular mechanisms of neutrophil involvement in COVID-19.

Main Methods:

  • Retrospective analysis of 55 COVID-19 patients categorized by disease severity.
  • Bayesian inference to quantify trends between leukocyte counts and lung lesions on chest CT scans.
  • RNA sequencing of lung specimens and bronchoalveolar lavage fluid (BALF) to analyze host immune cell transcriptional signatures.

Main Results:

  • Neutrophilia was observed in 6 of 8 severe COVID-19 patients, correlating with lesion progression.
  • Increasing neutrophil counts paralleled increased lesion severity on CT scans, indicating neutrophilia-induced lung injury.
  • Transcriptome analysis linked neutrophil activation to 17 neutrophil extracellular trap (NET)-associated genes, involving innate immunity and interactions with T, NK, and B cells.

Conclusions:

  • Excessive neutrophils and associated NETs are implicated in the pathogenesis of lung injury in COVID-19 pneumonia.
  • Neutrophil activation and NET formation may be key drivers of severe lung damage in COVID-19.
  • These findings highlight neutrophils as a potential therapeutic target for COVID-19.

Related Concept Videos